AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2274600
Drug: Clonidine (0.1-0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.1-0.3 mg bid)
Trial: 2274600
Drug: Propranolol (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (20-40 mg bid)
Trial: 30924254
Drug: 3-in-1 night
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-in-1 night facial serum (NFS) containing melatonin, bakuchiol, and ascorbyl tetraisopalmitate, applied once daily for 12 weeks
Trial: 24501946
Drug: Itopride (IG)
RxNorm normalized name: IG
DrugBank: Itopride (DB04924)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itopride (IG) 50 mg 3 times a day (tid)
Trial: 24501946
Drug: Domperidone (DP)
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (DP) 10 mg tid
Trial: 21626121
Drug: Betahistine dihydrochloride
RxNorm normalized name: Betahistine Dihydrochloride
DrugBank: Betahistine (DB06698)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betahistine dihydrochloride 288-480 mg/day
Trial: 10842890
Drug: Randomized clinical
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized clinical trial design measuring drug activity on acute parameters.
Trial: 9314427
Drug: Isradipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (2.5 to 10 mg BID) on high-salt diet
Trial: 9314427
Drug: Isradipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (2.5 to 10 mg BID) on low-salt diet
Trial: 3524465
Drug: Immunochemotherapy (L-I-C)
RxNorm normalized name: C.I. acid blue 324
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunochemotherapy (L-I-C)
Trial: 3524465
Drug: Post-operative chemotherapy
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative chemotherapy (L-I-C)
Trial: 3524465
Drug: Long-term continuous
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term continuous chemotherapy (L-C-C)
Trial: 3524465
Drug: Long-term continuous
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term continuous chemotherapy (L-C-C) with CQ+CPA+ADM+5-FU
Trial: 3524465
Drug: Post-operative radiation
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative radiation therapy
Trial: 3524465
Drug: Immunotherapy combined
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy combined with radiation therapy
Trial: 3524465
Drug: Bronchial arterial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchial arterial infusion (BAI)
Trial: 3524465
Drug: Short-term chemotherapy
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term chemotherapy (S-C)
Trial: 3524465
Drug: Long-term intermittent
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term intermittent chemotherapy (L-I-C)
Trial: 15761945
Drug: Albuterol dry
RxNorm normalized name: albuterol Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol dry powder inhalers with fine particle doses (FPDs) of 100 microg
Trial: 15761945
Drug: Albuterol dry
RxNorm normalized name: albuterol Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol dry powder inhalers with fine particle doses (FPDs) of 120 microg
Trial: 15761945
Drug: Albuterol dry
RxNorm normalized name: albuterol Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol dry powder inhalers with fine particle doses (FPDs) of 160 microg
Trial: 15761945
Drug: Albuterol dry
RxNorm normalized name: albuterol Dry Powder Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol dry powder inhalers
Trial: 12649515
Drug: Triflusal (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflusal (600 mg/d)
Trial: 10357343
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg plus dexamethasone 8 mg
Trial: 2802477
Drug: Endoscopic dilatation
RxNorm normalized name: phenylephrine hydrochloride Ophthalmic Solution [AK-Dilate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic dilatation and antireflux medication
Trial: 990784
Drug: Naloxone 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 40 mug administered intravenously one minute after birth
Trial: 29474712
Drug: Average on-treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Average on-treatment SBP ≤130 mmHg
Trial: 29474712
Drug: Average on-treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Average on-treatment SBP between 131 and 141 mmHg
Trial: 29474712
Drug: Average on-treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Average on-treatment SBP ≥142 mmHg
Trial: 23328286
Drug: 30 ml/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml/d lactulose
Trial: 23328286
Drug: 60 ml/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 ml/d lactulose
Trial: 23328286
Drug: 90 ml/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 ml/d lactulose
Trial: 20131262
Drug: LY2439821 (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2439821 (0.2 mg/kg)
Trial: 20131262
Drug: LY2439821 (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2439821 (2.0 mg/kg)
Trial: 20131262
Drug: LY2439821 (0.2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2439821 (0.2, 0.6, or 2.0 mg/kg)
Trial: 8746882
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol-valerat (E2V) and 10 mg dydrogesterone for 10 months
Trial: 2143712
Drug: d‐fenfluramine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐fenfluramine (30 mg daily)
Trial: 2143712
Drug: placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo plus low‐calorie diet (1500‐1200 kcal daily)
Trial: 26170041
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D and leucine-enriched whey protein nutritional supplement
Trial: 24021479
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance tests (OGTTs) and waist measurement
Trial: 17578485
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Pramipexole 0.5 mg and Domperidone 40 mg
Trial: 11037740
Drug: 5-isosorbide-mononitrate (5-ISMN)
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-isosorbide-mononitrate (5-ISMN) 30 mg administered orally three times daily for 4 weeks
Trial: 9265038
Drug: TX 1341
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TX 1341 (3 chewable lactate and citrate of magnesium tablets, each containing 120 mg of magnesium-element)
Trial: 9265038
Drug: Reference magnesium
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference magnesium (MAG2, 3 drinkable ampoules of pidolate of magnesium, each containing 122 mg of magnesium-element)
Trial: 27326985
Drug: Cetirizine, fexofenadine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine, fexofenadine, bilastine, desloratadine, or ebastine (daily oral dose for 8 weeks)
Trial: 27326985
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of antihistamine after 4 weeks for non-responders
Trial: 27326985
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antihistamine treatment)
Trial: 24736647
Drug: 1.4 g
RxNorm normalized name: MENTHOL 1.4 g in 100 g TOPICAL CREAM [Cetilar]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.4 g of EPA+DHA daily oil capsule supplements (n=24)
Trial: 12613519
Drug: Anthracycline treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline treatment with average dose of 174 mg/m2 (median 200 mg/m2) and mediastinum irradiation dose of 21 Gy (median 30 Gy)
Trial: 9750444
Drug: 7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 g of tranexamic acid after induction of anesthesia and 3 g after CPB (group T)
Trial: 7625419
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg for 2 years
Trial: 354736
Drug: Conventional bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional bowel preparation (CBP) using oral magnesium sulphate, enemas and rectal washouts
Trial: 354736
Drug: Oral neomycin
RxNorm normalized name: neomycin Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral neomycin and metronidazole for 48 h before operation added to all three methods of bowel preparation
Trial: 354736
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no bowel preparation)
Trial: 31805256
Drug: Low-dose NL003
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose NL003
Trial: 31805256
Drug: Middle-dose NL003
RxNorm normalized name: WHEAT MIDDLINGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Middle-dose NL003
Trial: 31805256
Drug: High-dose NL003
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose NL003
Trial: 29748353
Drug: Higher-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose edoxaban regimen (HD-ER)
Trial: 29748353
Drug: Lower-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose edoxaban regimen
Trial: 22267467
Drug: RBV dose
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RBV dose ≥3.0 g/kg
Trial: 22267467
Drug: RBV dose
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RBV dose <3.0 g/kg
Trial: 22267467
Drug: RBV dose
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RBV dose >3.0 g/kg
Trial: 12392039
Drug: BiDil (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BiDil (a fixed combination of hydralazine and isosorbide dinitrate)
Trial: 19382124
Drug: 200 microl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microl lavender capsules
Trial: 17498014
Drug: Standard preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard preoperative preparation (Control)
Trial: 11779724
Drug: Budesonide (1,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (1,600 microg/d) after initial treatment
Trial: 21055142
Drug: felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine 5 mg q.d + irbesartan 150 mg q.d (F + I group, n = 49)
Trial: 21055142
Drug: felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: felodipine 5 mg q.d + metoprolol 47.5 mg q.d (F + M group, n = 50)
Trial: 31355286
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccination (4 doses)
Trial: 31355286
Drug: Birth dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Birth dose of Hepatitis B vaccine
Trial: 11221809
Drug: Acarbose (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (300 mg/day)
Trial: 24431911
Drug: Voglibose (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose (0.9 mg/day)
Trial: 20307032
Drug: Intravitreal triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal triamcinolone injection
Trial: 20307032
Drug: Combined radial
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined radial optic neurotomy/intraocular triamcinolone injection
Trial: 18559703
Drug: HGF plasmid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HGF plasmid (high dose: 4.0 mg at days 0, 14, and 28)
Trial: 18559703
Drug: HGF plasmid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HGF plasmid (low dose: 0.4 mg at days 0, 14, and 28)
Trial: 18559703
Drug: HGF plasmid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HGF plasmid (middle dose: 4.0 mg at days 0 and 28)
Trial: 7847516
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen (50 micrograms of estradiol daily) with levonorgestrel-releasing intrauterine device
Trial: 7847516
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen (2 mg of estradiol valerate and 1 mg of norethisterone acetate daily)
Trial: 7074558
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy of megestrol, cyclophosphamide, and doxorubicin (MCA)
Trial: 7074558
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy of megestrol, cyclophosphamide, doxorubicin, and 5-fluorouracil (MCAF)
Trial: 7074558
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy of megestrol, 1-phenylalanine mustard, and 5-fluorouracil (MLF)
Trial: 31994751
Drug: Posterior-stabilized (PS)
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posterior-stabilized (PS) knee implant
Trial: 31994751
Drug: Cruciate-retaining (CR)
RxNorm normalized name: Gentiana cruciata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cruciate-retaining (CR) knee implant
Trial: 31994751
Drug: Medial-stabilized (MS)
RxNorm normalized name: MS-1819
DrugBank: MS-1819 (DB15004)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medial-stabilized (MS) knee implant
Trial: 26310261
Drug: Intravenous elafin
RxNorm normalized name: Elafin
DrugBank: Elafin (DB05161)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous elafin 200 mg
Trial: 24316098
Drug: Gastroretentive double-layered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastroretentive double-layered tablet formulation (GSS)
Trial: 22724877
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate (220 mg capsules, three times daily until end of chemotherapy)
Trial: 22724877
Drug: Placebo (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (three placebo capsules daily)
Trial: 15175869
Drug: Preplanning based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preplanning based on pretherapeutic transrectal ultrasound for the first HDR brachytherapy implant.
Trial: 15175869
Drug: Preplanning based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preplanning based on ultrasound from the first HDR brachytherapy implant for the second HDR brachytherapy.
Trial: 15175869
Drug: Postplans compared
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postplans compared to preplans for both HDR brachytherapy implants.
Trial: 11937460
Drug: Maximum medical
RxNorm normalized name: Maximum-H
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Maximum medical therapy
Trial: 11475718
Drug: Weihuigui Decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weihuigui Decoction (WHGD) 100 ml, three times a day for 2 weeks
Trial: 6587757
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg thrice daily)
Trial: 30897983
Drug: Dexpanthenol-containing ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexpanthenol-containing ointment
Trial: 26841799
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (VALID programme)
Trial: 9257738
Drug: Cisapride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (10 mg three times daily from day -2 to day 2)
Trial: 9257738
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g four times daily from day -2 to day 0)
Trial: 9257738
Drug: Sparfloxacin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sparfloxacin alone (400 mg single oral dose on day 0)
Trial: 8290678
Drug: Benztropine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benztropine (6 mg/day)
Trial: 3579261
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (40 mg/kg per day) for 5 days
Trial: 28033691
Drug: Memantine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (10 mg/day for week 1; 20 mg/day for weeks 2-6) plus olanzapine (15-20 mg/day)
Trial: 22076437
Drug: Low to
RxNorm normalized name: Mutton Tallow Topical application Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low to moderate doses of lithium
Trial: 20663600
Drug: Coronectomies with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coronectomies with endodontic treatments
Trial: 20663600
Drug: Coronectomies without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coronectomies without endodontic treatment
Trial: 17997267
Drug: Twice-weekly vouchers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly vouchers to reinforce abstinence and positive behaviors
Trial: 16393332
Drug: Periodic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Periodic administration of penicillin G and V (Group A)
Trial: 16393332
Drug: No repeated
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No repeated penicillin administration (Group B)
Trial: 1442478
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) infusion
Trial: 4066373
Drug: Mitomycin instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin instillation therapy
Trial: 4066373
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no mitomycin treatment)
Trial: 22370004
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care plus a cognitive behaviour therapy (CBT) booklet (BUC)
Trial: 22370004
Drug: Graded exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded exercise therapy (GET)
Trial: 17956953
Drug: GH replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH replacement therapy (individualized dose titration regimen)
Trial: 17956953
Drug: GH replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH replacement therapy (fixed body weight-based dosing regimen)
Trial: 17956953
Drug: GH replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH replacement therapy (both dosing regimens combined)
Trial: 16160131
Drug: High-dose radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radiation therapy (79.2 Gy)
Trial: 16160131
Drug: Conventional-dose radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional-dose radiation therapy (70.2 Gy)
Trial: 12100367
Drug: UFH (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH (5000 IU subcutaneously thrice daily)
Trial: 8555803
Drug: Levodopa and
RxNorm normalized name: levodopa and decarboxylase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa and dopa decarboxylase inhibitor (arm 1)
Trial: 8555803
Drug: Levodopa and
RxNorm normalized name: levodopa and decarboxylase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa and decarboxylase inhibitor in combination with selegiline (arm 2)
Trial: 2355103
Drug: labetalol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: labetalol (100 mg bid)
Trial: 2355103
Drug: hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: hydrochlorothiazide (HCTZ) (25 mg bid)
Trial: 872445
Drug: Long-term diphenylhydantoin
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term diphenylhydantoin (DPH) treatment
Trial: 872445
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of DPH treatment
Trial: 28885425
Drug: 10-mL 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mL 1% lidocaine paracervical nerve block
Trial: 25845406
Drug: Vagisan(®) Moisturising
RxNorm normalized name: Vagistat
DrugBank: Tioconazole (DB01007)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vagisan(®) Moisturising Cream (CREAM)